Wenfeng Zhuo
Overview
Explore the profile of Wenfeng Zhuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao J, Lin E, Bai Z, Jia Y, Wang B, Dai Y, et al.
BMC Cancer
. 2025 Mar;
25(1):391.
PMID: 40038634
No abstract available.
2.
Lin E, Song M, Wang B, Shi X, Zhao J, Fu L, et al.
Eur J Nucl Med Mol Imaging
. 2025 Jan;
PMID: 39836214
Purpose: Cancer-associated fibroblasts (CAFs) are the primary stromal component of the tumor microenvironment in hepatocellular carcinoma (HCC), affecting tumor progression and post-resection recurrence. Fibroblast activation protein (FAP) is a key...
3.
Zeng G, Liu X, Zheng Z, Zhao J, Zhuo W, Bai Z, et al.
Lipids Health Dis
. 2024 Dec;
23(1):424.
PMID: 39731125
Background: There is still no reliable therapeutic targets and effective pharmacotherapy for metabolic dysfunction-associated steatotic liver disease (MASLD). RASD1 is short for Ras-related dexamethasone-induced 1, a pivotal factor in various...
4.
Zhao Y, Han S, Zeng Z, Zheng H, Li Y, Wang F, et al.
Theranostics
. 2024 Dec;
14(18):7088-7110.
PMID: 39629121
Resistance to sorafenib remains a major challenge in the systemic therapy of liver cancer. However, the involvement of lipid metabolism-related lncRNAs in this process remains unclear. Different expression levels of...
5.
Hu Y, Li Y, Xiong H, Zhang Y, Wang F, Zhuo W, et al.
Int J Biol Sci
. 2024 Sep;
20(11):4341-4363.
PMID: 39247822
Macrophages are the most abundant alternative immune cells in the tumor microenvironment (TME). The cross-talk between macrophages and tumor cells provides an important shelter for the occurrence and development of...
6.
Yang S, Li A, Lv L, Duan J, Zheng Z, Zhuo W, et al.
Onco Targets Ther
. 2024 Jun;
17:423-438.
PMID: 38827823
Background: Nicotinamide (NAM+) regulates redox and metabolic activities in the mitochondria. The intention of the research was to identify key genes that relate to nicotinamide in hepatocellular carcinoma (HCC). Methods:...
7.
Li A, Xie J, Lv L, Zheng Z, Yang W, Zhuo W, et al.
Int J Oncol
. 2024 Apr;
64(6).
PMID: 38639179
The exosomal pathway is an essential mechanism that regulates the abnormal content of microRNAs (miRNAs) in hepatocellular carcinoma (HCC). The directional transport of miRNAs requires the assistance of RNA‑binding proteins...
8.
Zeng Z, Wang J, Xu F, Hu P, Hu Y, Zhuo W, et al.
Int J Biol Sci
. 2024 Mar;
20(5):1744-1762.
PMID: 38481809
Glycolysis exerts a key role in the metabolic reprogramming of cancer. Specific long non-coding RNAs (lncRNAs) have been identified to exhibit oncogenic glycolysis regulation. Nevertheless, the precise mechanisms by which...
9.
Zhao J, Lin E, Bai Z, Jia Y, Wang B, Dai Y, et al.
BMC Cancer
. 2023 Dec;
23(1):1198.
PMID: 38057830
Background: Due to the high drug resistance of hepatocellular carcinoma (HCC), sorafenib has limited efficacy in the treatment of advanced HCC. Cancer-associated fibroblasts (CAFs) play an important regulatory role in...
10.
Wang F, Hu Y, Wang H, Hu P, Xiong H, Zeng Z, et al.
J Exp Clin Cancer Res
. 2023 Oct;
42(1):267.
PMID: 37840133
Background: Long non-coding RNAs (LncRNAs) have been extensively studied to play essential roles in tumor progression. However, more in-depth studies are waiting to be solved on how lncRNAs regulate the...